Wed, September 15, 2010
[ Wed, Sep 15th 2010 ]: Market Wire
Qtrax Beta Available in India
Tue, September 14, 2010
Mon, September 13, 2010
Sun, September 12, 2010
Fri, September 10, 2010
Thu, September 9, 2010
Wed, September 8, 2010
Tue, September 7, 2010
Sat, September 4, 2010
[ Sat, Sep 04th 2010 ]: Market Wire
Transdel Pharmaceuticals
Fri, September 3, 2010
Thu, September 2, 2010
Wed, September 1, 2010
Tue, August 31, 2010
Mon, August 30, 2010
Sun, August 29, 2010
Fri, August 27, 2010
[ Fri, Aug 27th 2010 ]: Market Wire
?????????????????????
Thu, August 26, 2010
Wed, August 25, 2010
Tue, August 24, 2010

Array BioPharma to Present at the Rodman & Renshaw Global Investment Conference and the Stifel Nicolaus Healthcare Conference


//health-fitness.news-articles.net/content/2010/ .. d-the-stifel-nicolaus-healthcare-conference.html
Published in Health and Fitness on by Market Wire   Print publication without navigation


BOULDER, Colo.--([ BUSINESS WIRE ])--Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the Rodman & Renshaw Global Investment Conference and the Stifel Nicolaus Healthcare Conference. The public is welcome to participate in the conferences through webcasts on the Array BioPharma website.

Event:

Rodman & Renshaw Global Investment Conference

Presenter:

Robert E. Conway, Chief Executive Officer, Array BioPharma

Date:

Monday, September 13, 2010

Time:

10:00 a.m. Eastern Time

Location:

New York Palace Hotel, New York, NY

Webcast:

[ www.arraybiopharma.com ]

Event:

Stifel Nicolaus Healthcare Conference

Presenter:

Robert E. Conway, Chief Executive Officer, Array BioPharma

Date:

Wednesday, September 15, 2010

Time:

2:05 p.m. Eastern Time

Location:

Four Seasons, Boston, MA

Webcast:

[ www.arraybiopharma.com ]

About Array BioPharma

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. Our proprietary drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target proteins and are aimed at significant unmet medical needs. For more information on Array, please go to [ www.arraybiopharma.com ].


Publication Contributing Sources

Publication Sponsors
[ Last Sunday ] - Oceanside Rental Gear